Premier Medical Corporation Limited supplies and develops cost effective Point-of-Care Rapid tests. These rapid diagnostic tests are both qualitative and semi-quantitative to detect infectious diseases, fertility, cancer screening, cardiac marker tests, thyroid range tests and drugs of abuse tests through analysis of blood and other body fluids. These tests are marketed under the brand names “First Response® / AccuSign® and AQCheck®.”

 

In March 1997, the company established its manufacturing facility at Daman, India. The company has established a strong distribution network throughout India, Africa, Europe, and South America, and has developed strategic co-marketing alliances with the leading medical companies. The company currently services diverse customer groups, i.e. health care professionals such as physicians, laboratories, hospitals, government health centres, distributors, and retailers.

 

The company has entered into strategic alliances with medical diagnostic and device developing companies to develop, manufacture and market products throughout the world. The company selected India as its worldwide trans-national operational site to transfer critical technologies and to provide its service to the customers of India and developing markets.

 

First Response HIV 1-2.O rapid test, is the company’s flagship product and is accepted worldwide and is used by customers around the world. It has been evaluated and approved by various agencies such as CDC-USA, WHO, Pasteure Institute and governments.

 

The company has not only received government approvals to manufacture and market products, it is also backed up by its strong Quality Management System under ISO 9001:2008 and ISO 13485:2003 and accredited by renowned Notifying Bodies.